Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv
- 31 December 1996
- journal article
- Published by Elsevier BV in Molecular Immunology
- Vol. 33 (17-18), 1389-1401
- https://doi.org/10.1016/s0161-5890(96)00078-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Myasthenia GravisThe New England Journal of Medicine, 1994
- PROTECTION OF PORCINE AORTIC ENDOTHELIAL CELLS FROM COMPLEMENT-MEDIATED CELL LYSIS AND ACTIVATION BY RECOMBINANT HUMAN CD59Transplantation, 1994
- Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 diseaseBiotherapy, 1993
- Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.The Journal of Experimental Medicine, 1993
- Mouse Variable‐Region Gene Families: Complexity, Polymorphism and Use in non‐Autoimmune ResponsesImmunological Reviews, 1992
- Antibody framework residues affecting the conformation of the hypervariable loopsJournal of Molecular Biology, 1992
- The control of homologous lysisImmunology Today, 1991
- Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulinsJournal of Molecular Biology, 1990
- Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardiumClinical and Experimental Immunology, 1990
- Canonical structures for the hypervariable regions of immunoglobulinsJournal of Molecular Biology, 1987